Integrating multiple omics information in the era of precision oncology

Direct activation of STING in the tumour microenvironment leads to potent and systemic tumour regression and immunity

Successes and challenges in designing combination immunotherapy clinical trials for breast cancer

Understanding personalised medicine - the e-learning course

Breast cancer risk prediction models improved by adding multiple biological markers of risk

Physical activity may improve prostate cancer prognosis

Inflammatory microenvironment regulates colorectal cancer progression

Mechanisms of immune escape in non-Hodgkin lymphoma

'Helper' T Cells effective in therapy, and shows early clinical responses in patients with metastatic cancer

Innovations in assessing patient outcomes

Repopulation of cancer stem cells in therapeutic resistance

Technologies for personalised cancer immunotherapies